Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Defenses Against Pathogens and Herbivores

Defenses Against Pathogens and Herbivores

Plants present a rich source of nutrients for many organisms, making it a target for herbivores and infectious agents. Plants, though lacking a proper immune system, have developed an array of constitutive and inducible defenses to fend off these attacks.

Limits to Natural Selection

Limits to Natural Selection

Organisms that are well-adapted to their environment are more likely to survive and reproduce. However, natural selection does not lead to perfectly adapted organisms. Several factors constrain natural selection.

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

1206 genomes reveal origin and movement of <i>Aedes aegypti</i> driving increased dengue risk.

Science (New York, N.Y.)·2025

Same author

Whole-genome sequencing confirms multiple species of Galapagos giant tortoises.

Evolution; international journal of organic evolution·2024

Same author

Predicting Environmental and Ecological Drivers of Human Population Structure.

Molecular biology and evolution·2023

Same author

Pleistocene parades of carnivores into North America.

Molecular ecology·2022

Same author

Coyotes in New York City Carry Variable Genomic Dog Ancestry and Influence Their Interactions with Humans.

Genes·2022

Same author

The recombination landscape of the Khoe-San likely represents the upper limits of recombination divergence in humans.

Genome biology·2022

Search research articles

Related Experiment Video

Updated: Mar 12, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

How elephants beat cancer.

Stephen J Gaughran¹, Evlyn Pless¹, Stephen C Stearns¹

¹Department of Ecology and Evolutionary Biology, Yale University, New Haven, United States.

|November 1, 2016

Summary

This summary is machine-generated.

Elephants possess multiple copies of the tumor suppressor gene, TP53, which significantly lowers their cancer risk. This genetic duplication offers robust protection against developing various forms of cancer.

Keywords:

African elephant Asian elephant aardvark armadillo cell biology evolutionary biology genomics hyrax

More Related Videos

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Related Experiment Videos

Last Updated: Mar 12, 2026

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

Area of Science:

Comparative oncology
Genetics
Evolutionary biology

Background:

Cancer is a significant threat to mammalian survival.
The TP53 gene is a critical tumor suppressor, often mutated in human cancers.
Understanding natural cancer resistance mechanisms can inform human health strategies.

Purpose of the Study:

To investigate the genetic basis of cancer resistance in elephants.
To explore the role of the TP53 gene in elephant cancer prevention.

Main Methods:

Comparative genomic analysis of elephant DNA.
Functional studies of TP53 gene copies in elephant cells.

Main Results:

Elephants possess multiple functional copies of the TP53 gene.
These TP53 duplications are associated with enhanced cellular response to DNA damage.
Evidence suggests these duplications contribute to elephants' naturally low cancer rates.

Conclusions:

Multiple TP53 gene copies are a key adaptation for cancer resistance in elephants.
This genetic strategy provides a powerful model for understanding cancer prevention.
Further research into TP53 gene function could yield novel cancer therapies.